Skip to main content

Complement-Dependent Cytotoxicity

  • Reference work entry
  • First Online:
Encyclopedia of Cancer
  • 231 Accesses

Definition

CDC refers to the lysis of a target cell in the presence of complement system proteins. The complement activation pathway is initiated by the binding and fixation of the first component of the complement system (CIq) to the fragment crystalline (Fc) region of a (therapeutic) antibody complexed with a cognate antigen. The end result is a membrane attack complex that generates a hole in the cell membrane, ultimately causing cell lysis and death.

Diabody

Immunotherapy

Interferon-α

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

(2011). Complement-Dependent Cytotoxicity. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16483-5_1286

Download citation

Publish with us

Policies and ethics